WHO's endorsement of the R21/Matrix-M malaria vaccine signifies a breakthrough in malaria prevention. Driven by safety and efficacy, this prequalification promises increased vaccine access for children in malaria-endemic regions, bolstering efforts to combat the disease's toll on global health.